Pitching companies at "Entrepreneurship & Value Creation in Life Science" 22/5 during #gbgtechweek

GU Ventures and Sahlgrenska Science Park are the organizers for the "Entrepreneurship & Value Creation within Life Science"- event during #gbgtechweek next week. We would now like to introduce to you the pitching companies you´ll meet during the event.

The aim is to fulfill your curiosity and interest on the topics entrepreneurship and value creation within life science. As one part of the program, we have intvited three companies within the life science area to pitch. Let us introduce the companies a bit more:

Itedale Namro Redwan, Scientific Officer and Senior Principal Scientist at CELLINK

The company focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products, and in the future, for clinical applications. CELLINK’s innovative and patent pending bioink is a biomaterial innovation that enables human cells to grow and thrive such as they would in the natural human body environment. Today, the company’s disruptive technology platform is being utilized to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments. https://cellink.com/

Petter Knagenhjelm, owner and founder of Opatus

Opatus AB is a Swedish medtech company that improves the quality of life for people with attention difficulties through an improved, smartphone-based diagnostic support and treatment follow-up method. We focus on providing tools for objective assessment of various human profiles with the aim to support professionals in the determination of possible diagnoses, such as ADHD. We provide a complementary neuropsychiatric tool for simultaneous measurements of Attention, Impulsivity and Activity. OPATUS CPTA increases diagnosis precision and is easy to use, quick, cost effective and accessible. https://opatus.se/

Linn Hägg, Co-Funder, Marketing and Sales Director VP at MyOroface

MYoroface is the company that has developed, produced, patented and registered IQoro^®.
IQoro^® is a new and unique neuromuscular treatment method that requires just 30 seconds’ exercise, three times per day. It works by training and strengthening the muscles, and by stimulating the brain to regenerate the pathways that control them. IQoro^® helps people with problems in swallowing, with hiatus hernia, facial paralysis, speech, snoring or sleep apnoea problems, and more. https://www.iqoro.com

Don´t miss your chance to meet these companies and get an insight to the future of life science!

When: Tuesday 22/5 12:00-16:00
Where: Arvid Carlsson conference room at Academicum, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 3.

We look forward to meet you, register here!

For more information, please contact:

Magdalena Rosinski, Project Manager GU Ventures
Phone: +46 (0) 7 33 43 73 67
Email: magdalena.rosinski@ventures.gu.se